Deadline: 23-Jul-25
The Pfizer Inc. and Astellas are collaborating to provide grant support for continuing professional education in bladder cancer.
This competitive grant program seeks to support independent medical education activities that will increase knowledge of new guideline-based treatment recommendations.
Focus Areas
- Projects considered for grant support will focus on one or more of the following:
- Application of guideline recommended care in first-line locally advanced or metastatic urothelial carcinoma (la/mUC):
- Holistic management of patients with la/mUC, including but not limited to:
- selection and sequencing of therapies
- early identification, management, and monitoring of adverse events
- adverse event mitigation strategies to employ before or during treatment
- Best practices for multidisciplinary teams to deliver safe and effective care for la/Muc patients, particularly community and rural practice settings with a focus on advanced practice provider education
- Strengthening shared decision-making between health care providers andpatients/patient caregivers
- Holistic management of patients with la/mUC, including but not limited to:
- Application of guideline recommended care in first-line locally advanced or metastatic urothelial carcinoma (la/mUC):
Funding Information
- Individual projects requesting up to $250,000 will be considered although projects with budgets under this cap (either through multi-supported or smaller, focused educational activities) will receive preferential consideration.
- Funding will be allocated for 1-2 larger projects with the majority of the total available budget going toward multiple smaller projects (e.g. $50,000 – $150,000.)
- The estimated total available budget related to this RFP is $1,300,000 USD
Target Audience
- The intended learner audience can include urologists, medical oncologists, Advanced Practitioners (APPs/PA/NPs), nurses, other healthcare professionals on the multidisciplinary care team responsible for the treatment of patients with urothelial cancer, and/or patients and caregivers in community and academic settings
Geographic Location
- The geographic scope of this RFP can reach global learner audiences, however, the United States should be the primary priority.
Eligible Activities
- Examples of educational formats that will be considered under this RFP include but are not limited to:
- Multi-activity or tiered education that builds over time such as a series of activities or curriculum-based learning
- Tethered programs, incorporating patients/caregivers into learning activities On agenda educational sessions during live conferences or satellite symposia adjacent to major conferences (including those through Spring of 2026)
- Grand Rounds or tumor boards
- Expert interviews recorded at live conferences, conference coverage reviews
- Online articles, training courses, webinars, podcasts
- All learning resources such as videos, infographics, animations
Eligibility Criteria
- Only organizations are eligible to receive grants, not individuals or medical practice groups.
- If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The project/program lead must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc.
- For projects offering continuing education credit, the requesting organization must be accredited.
For more information, visit Pfizer.
